Regeneron (REGN) First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma
Go back to Regeneron (REGN) First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma| Regeneron (NASDAQ: REGN) | Delayed: 612.50 +2.56 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $609.94 | 52 Week High | $592.36 | |||
| Open | $604.46 | 52 Week Low | $325.35 | |||
| Day High | $613.56 | P/E | 160.76 | |||
| Day Low | $594.90 | EPS | $3.81 | |||
| Volume | 1,604,280 | |||||

